147 related articles for article (PubMed ID: 3433247)
1. Kinetics and in vivo distribution of in-111-labelled platelets and platelet function in familial hypercholesterolaemia.
Wessels P; Heyns AD; Esterhuysen AJ; Badenhorst PN; Lötter MG; Pieters H; Kotzè HF
Thromb Haemost; 1987 Oct; 58(3):811-6. PubMed ID: 3433247
[TBL] [Abstract][Full Text] [Related]
2. [Initial 111In-platelet kinetics: indicator of platelet sequestration/destruction site or quality control of platelet labelling?].
Todorović-Tirnanić M; Obradović V; Rolović Z; Suvajdzić N; Elezović I; Colović M; Pavlović S; Starcević V; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):101-18. PubMed ID: 16405234
[TBL] [Abstract][Full Text] [Related]
3. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
[TBL] [Abstract][Full Text] [Related]
4. Kinetic and functional studies of platelets, fibrinogen, and plasminogen in patients with hepatic cirrhosis.
Stein SF; Harker LA
J Lab Clin Med; 1982 Feb; 99(2):217-30. PubMed ID: 7061918
[TBL] [Abstract][Full Text] [Related]
5. A quantitative study of indium-111-oxine platelet kinetics in acute and chronic renal transplant rejection.
Heyns AD; Lötter MG; Pieters H; Pauw FH; Badenhorst PN; Wessels P; Minnaar PC
Clin Nephrol; 1982 Oct; 18(4):174-82. PubMed ID: 6814802
[TBL] [Abstract][Full Text] [Related]
6. The interpretation of platelet kinetic studies for the identification of sites of abnormal platelet destruction.
Peters AM; Saverymuttu SH; Wonke B; Lewis SM; Lavender JP
Br J Haematol; 1984 Aug; 57(4):637-49. PubMed ID: 6430336
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
[TBL] [Abstract][Full Text] [Related]
8. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia.
Lowe GD; Drummond MM; Third JL; Bremner WF; Forbes CD; Prentice CR; Lawrie TD
Thromb Haemost; 1980 Feb; 42(5):1503-7. PubMed ID: 7368154
[TBL] [Abstract][Full Text] [Related]
9. Platelet deposition at angioplasty sites and platelet survival time after PTA in iliac and femoral arteries: investigations with indium-111-oxine labelled platelets in patients with ASA (1.0 g/day)-therapy.
Minar E; Ehringer H; Ahmadi R; Dudczak R; Porenta G
Thromb Haemost; 1987 Aug; 58(2):718-23. PubMed ID: 2960029
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of (33P)2MeS-ADP binding sites on platelets with secretion defect, normal granule stores and normal thromboxane A2 production. Evidence that ADP potentiates platelet secretion independently of the formation of large platelet aggregates and thromboxane A2 production.
Cattaneo M; Lombardi R; Zighetti ML; Gachet C; Ohlmann P; Cazenave JP; Mannucci PM
Thromb Haemost; 1997 May; 77(5):986-90. PubMed ID: 9184415
[TBL] [Abstract][Full Text] [Related]
11. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.
Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of In-111-platelets in the baboon: II. In vitro distribution and sites of sequestration.
Kotzé HF; Lötter MG; Badenhorst PN; Heyns AD
Thromb Haemost; 1985 Jun; 53(3):408-10. PubMed ID: 4049311
[TBL] [Abstract][Full Text] [Related]
13. [Selected parameters of blood platelet function in patients with myeloproliferative syndrome].
Zuk E
Ann Acad Med Stetin; 1998; 44():137-54. PubMed ID: 9857536
[TBL] [Abstract][Full Text] [Related]
14. Effects of recombinant human granulocyte-macrophage colony-stimulating factor on platelet survival and activation using a nonhuman primate model.
Tomer A; Stahl CP; McClure HM; Anderson DC; Myers LA; Liehl E; Winton EF
Exp Hematol; 1993 Nov; 21(12):1577-82. PubMed ID: 8405239
[TBL] [Abstract][Full Text] [Related]
15. Influence of platelet membrane sialic acid and platelet-associated IgG on ageing and sequestration of blood platelets in baboons.
Kotzé HF; van Wyk V; Badenhorst PN; Heyns AD; Roodt JP; Lötter MG
Thromb Haemost; 1993 Oct; 70(4):676-80. PubMed ID: 8115995
[TBL] [Abstract][Full Text] [Related]
16. Kinetics and fate of (111)Indium-oxine labelled blood platelets in asplenic subjects.
Heyns AD; Lötter MG; Badenhorst PN; van Reenen O; Pieters H; Minnaar PC
Thromb Haemost; 1980 Oct; 44(2):100-4. PubMed ID: 6779398
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and in vivo redistribution of (111)Indium-labelled human platelets after intravenous protamine sulphate.
Heyns AD; Lötter MG; Badenhorst PN; Kotze H; Killian FC; Herbst C; van Reenen OR; Minnaar PC
Thromb Haemost; 1980 Oct; 44(2):65-8. PubMed ID: 7455993
[TBL] [Abstract][Full Text] [Related]
18. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
19. The influence of platelet-graft interaction on platelet survival in patients with aortobifemoral Dacron grafts.
Kotzé HF; Heyns AD; Nel CJ; Roodt JP; Herbst CP; Badenhorst PN; Lötter MG
S Afr Med J; 1992 Jan; 81(1):27-31. PubMed ID: 1530891
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of nicotine infusion on platelets in nicotine users with normal and impaired renal function.
Whiss PA; Lundahl TH; Bengtsson T; Lindahl TL; Lunell E; Larsson R
Toxicol Appl Pharmacol; 2000 Mar; 163(2):95-104. PubMed ID: 10698667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
